Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by priceless2on Oct 22, 2020 8:23am
219 Views
Post# 31760849

RE:RE:sciencedirect - rvx208 + COVID

RE:RE:sciencedirect - rvx208 + COVIDNarmac, Come on Man, any deal with  an upfront payment with a large BP will instantly give RVX massive credibility to not only the science, the BTD and success of the BETONMACEs2 trial,  We will move up 100% , the question is by what multiple, 100% , 200% 500%,   Narmac , i assume you know the value of a successful BTD drug to a BP,is  $8 billion USD, a deal with RVX will be 100 %discounted to that value but even 10% to 20 of that value is a possbility on a signed parnership deal . I think you smoked too much of your ganga on that comment,  Will get a deal it just will take a little longer 
<< Previous
Bullboard Posts
Next >>